Literature DB >> 20888650

miRNAs in multiple sclerosis: regulating the regulators.

Mireia Guerau-de-Arellano, Amy E Lovett-Racke, Michael K Racke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20888650      PMCID： PMC2991561          DOI： 10.1016/j.jneuroim.2010.08.025

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN： 0165-5728            Impact factor:   3.478


× No keyword cloud information.
  29 in total

1.  Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.

Authors:  Koen Venken; Niels Hellings; Karen Hensen; Jean-Luc Rummens; Robert Medaer; Marie B D'hooghe; Bénédicte Dubois; Jef Raus; Piet Stinissen
Journal:  J Neurosci Res       Date:  2006-06       Impact factor: 4.164

Review 2.  Evolution of microRNAs.

Authors:  Andrea Tanzer; Peter F Stadler
Journal:  Methods Mol Biol       Date:  2006

Review 3.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

4.  CD4+CD25+FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.

Authors:  Manoj Kumar; Norman Putzki; Volker Limmroth; Ralph Remus; Monika Lindemann; Dietmar Knop; Norbert Mueller; Cornelia Hardt; Ernst Kreuzfelder; Hans Grosse-Wilde
Journal:  J Neuroimmunol       Date:  2006-09-29       Impact factor: 3.478

5.  Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.

Authors:  Koen Venken; Niels Hellings; Marielle Thewissen; Veerle Somers; Karen Hensen; Jean-Luc Rummens; Robert Medaer; Raymond Hupperts; Piet Stinissen
Journal:  Immunology       Date:  2007-09-25       Impact factor: 7.397

6.  Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.

Authors:  Koen Venken; Niels Hellings; Tom Broekmans; Karen Hensen; Jean-Luc Rummens; Piet Stinissen
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

7.  MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways.

Authors:  Qinyan Yin; Jane McBride; Claire Fewell; Michelle Lacey; Xia Wang; Zhen Lin; Jennifer Cameron; Erik K Flemington
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

8.  CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.

Authors:  Y Jee; W H Piao; R Liu; X F Bai; S Rhodes; R Rodebaugh; D I Campagnolo; F D Shi; T L Vollmer
Journal:  Clin Immunol       Date:  2007-07-16       Impact factor: 3.969

9.  Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells.

Authors:  Nabila Seddiki; Brigitte Santner-Nanan; Jeff Martinson; John Zaunders; Sarah Sasson; Alan Landay; Michael Solomon; Warwick Selby; Stephen I Alexander; Ralph Nanan; Anthony Kelleher; Barbara Fazekas de St Groth
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

10.  CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells.

Authors:  Weihong Liu; Amy L Putnam; Zhou Xu-Yu; Gregory L Szot; Michael R Lee; Shirley Zhu; Peter A Gottlieb; Philipp Kapranov; Thomas R Gingeras; Barbara Fazekas de St Groth; Carol Clayberger; David M Soper; Steven F Ziegler; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307
View more
  3 in total

1.  miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis.

Authors:  Kristen M Smith; Mireia Guerau-de-Arellano; Stefan Costinean; Jessica L Williams; Arianna Bottoni; Gina Mavrikis Cox; Abhay R Satoskar; Carlo M Croce; Michael K Racke; Amy E Lovett-Racke; Caroline C Whitacre
Journal:  J Immunol       Date:  2012-07-06       Impact factor: 5.422

2.  NF-κB/mTOR/MYC Axis Drives PRMT5 Protein Induction After T Cell Activation via Transcriptional and Non-transcriptional Mechanisms.

Authors:  Lindsay M Webb; Janiret Narvaez Miranda; Stephanie A Amici; Shouvonik Sengupta; Gregory Nagy; Mireia Guerau-de-Arellano
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

3.  Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways.

Authors:  Zinah Zamil Al-Ghezi; Kathryn Miranda; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.